Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.076 AUD | -2.56% | -2.56% | -6.17% |
20/03 | Australia's Tax Agency Publishes Ruling on Invex Therapeutics' Capital Return | MT |
16/02 | Invex Therapeutics Narrows Fiscal H1 Loss on Lower R&D Expenses | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-6.17% | 3.82M | |
+42.59% | 50.93B | |
-0.38% | 42.12B | |
+49.62% | 42.05B | |
-7.20% | 29.18B | |
+13.31% | 26.02B | |
-22.15% | 18.9B | |
+8.08% | 13.21B | |
+24.37% | 12.17B | |
+30.19% | 12.16B |
- Stock Market
- Equities
- IXC Stock
- News Invex Therapeutics Ltd
- Invex Therapeutics Secures Regulatory, Ethics Approval for Phase 3 Neurological Trial in New Zealand